SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-009306
Filing Date
2022-03-09
Accepted
2022-03-09 16:05:33
Documents
14
Period of Report
2022-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxdx-8k_20220309.htm   iXBRL 8-K 37480
2 EX-99.1 rxdx-ex991_6.htm EX-99.1 212034
3 GRAPHIC gxiejmcyr30c000001.jpg GRAPHIC 17559
  Complete submission text file 0001564590-22-009306.txt   418071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20220309.xsd EX-101.SCH 5745
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20220309_lab.xml EX-101.LAB 19410
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20220309_pre.xml EX-101.PRE 11618
8 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-8k_20220309_htm.xml XML 3556
Mailing Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121
Business Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 (858) 200-7888
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40187 | Film No.: 22725412
SIC: 2834 Pharmaceutical Preparations